Press Release

CD BIOSCIENCES LAUNCHES NEW SUPER-RESOLUTION IMAGING TECHNOLOGY FOR BIOMEDICAL RESEARCH



CD BioSciences introduced its new services based on super-resolution imaging technology for customers.

FOR IMMEDIATE RELEASE

07/08/2023

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, introduced its new services based on super-resolution imaging technology to assist researchers in studying various cellular activities in cellular structures, such as DNA/RNA and protein interactions, DNA replication and transcription, vesicle motility, and bacterial transcription.

Microscopes are the most common research tools used in biological research. Researchers typically use electron microscopes to study subcellular structures or optical microscopes to investigate whole living cells. However, traditional microscopes have limited resolution. For example, when the distance between two or more fluorophores is within a few hundred nanometers, the images become blurred. In addition, traditional microscopes cannot directly observe cellular structures and biomolecular interactions because biological structures such as protein complexes, the Golgi apparatus, and the cytoskeleton are below the diffraction limit of traditional microscopes.

CD BioSciences has solved this problem with super-resolution imaging technology, which enables scientists to directly observe cell structures and biomolecular interactions, and study various cell activities in cell structure, such as DNA/RNA and protein interaction, DNA replication and transcription, vesicle movement and bacterial transcription. It has a number of advantages over traditional light microscopy, including high resolution, the ability to study protein structure at the organelle level, and the ability to follow the movement of individual molecules in cells in real time. These advantages make super-resolution imaging technology a valuable tool for researchers studying the mechanisms of cell physiology.

Furthermore, super-resolution microscopy breaks the resolution barrier while maintaining the minimally invasive nature of optical microscopy. It enables the observation of fine structures and molecular activities in the 10-100 nanometer resolution range by providing 20 times the imaging resolution of optical microscopy. It works by effectively reducing the point spread function or ensuring that the fluorophores of a sample are not too close together to prevent blurring.

Stimulated emission depletion microscopy (STED), structured illumination microscopy (SIM), stochastic optical reconstruction microscopy (STORM), and two-photon excitation microscopy (TPE) are the most commonly used super-resolution microscopy techniques. These techniques produce super-resolution images in the low nanometer range, allowing observation of intracellular molecular interactions and fine cellular structures.

CD BioSciences specializes in the development and application of super-resolution imaging technology. It offers a wide range of services including image analysis and consulting. For more information about the new super-resolution imaging technology, please visit https://www.bioimagingtech.com/super-resolution-imaging-technology.html.

About CD BioSciences

CD BioSciences is a biotechnology company committed to the development of imaging technology for many years. Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein molecules.

Tags:
Super-Resolution Imaging Technol  |  CD BioSciences  |  

---

Organisation Profile:
CD BioSciences is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSciences is the one-stop shop devoted to researchers making advancements in signaling pathway studies.






Press release contact details for CD BioSciences

NameCD BioSciences
Tel
Fax
Email
Websitehttps://www.cd-biosciences.com/
OrganisationCD BioSciences
Address
Town
County
Postcode




Other press releases from CD BioSciences

CD BioSciences Introduces New Solutions to Support Cell Death Studies
CD BioSciences Launches Scaffold-Based Technologies for 3D Cell Culture
CD BioSciences Launches Hyperspectral Imaging Technology for Food Safety
CD BioSciences Introduces New Cell Death Solutions to Facilitate Research
CD BioSciences Launches Fluorescence Correlation Spectroscopy
CD BioSciences Introduces Various Solutions for Studying Apoptotic Cell Death
CD BioSciences Launches Nanoparticles Imaging Technology for Scientists
CD BioSciences Introduces Multiple Solutions for Type II Cell Death Research
CD BioSciences Launches New Time-Lapse Imaging Services for Scientists
CD BioSciences Launches New Solutions for Microautophagy Research
CD BioSciences Announces New Immunofluorescence-Based Services
CD BioSciences Launches New Solutions for Type III Cell Death Research
CD BioSciences Launches New Super-Resolution Imaging Technology for Biomedical Research
CD BioSciences Announces New Research Solutions on Mitotic Catastrophe
CD BioSciences Announces New Single Molecule Fluorescence Imaging Technology
CD BioSciences Introduces New Metabolic Homeostasis Research Solutions
CD BioSciences Launches New Services to Study Catabolism in Diabetes
CD BioSciences Launches New 3D Tissue Imaging Services
HighRun DataScience Launches Data Science Platform for Global Customers
CD BioSciences Announces New Solutions for Studying Anabolism
CD Biosciences Introduces 3D Image Analysis Services For Bioimaging Research
CD BioSciences Expands Portfolio with Wide Range of Embedding Resins and Kits for Electron and Light Microscopy
CD BioSciences Announces New Solutions for Glucose Homeostasis Research
CD Biosciences Announces Expanded Capabilities for Mechanistic Target of Rapamycin Research in Diabetes and Metabolism
CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry
CD BioSciences Launches New Range of In Vivo Imaging Reagents for Scientific Research
CD BioSciences Introduces IHC Ancillaries for Enhanced Research and Diagnostics
CD BioSciences Announces Comprehensive Range of Nervous System Tissue Microarrays

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.